Fig. 8From: RAS signaling in carcinogenesis, cancer therapy and resistance mechanismsAcquired mechanisms of resistance to KRASG12C inhibitors. (A-D) Frequency of acquired resistance mutations in MAPK pathway genes, as documented in references [219,220,221,222]Back to article page
